N Novonesis (Novozymes) B
N
Closed
427.8 -0.19
Overview
Share price change
24h
Min
423.9
Max
428.7
Income | -27M 172M |
|---|---|
Sales | -3M 1.1B |
P/E Sector Avg | 42.448 40.288 |
EPS | 2.84 |
Dividend yield | 0.21 |
Profit margin | 15.383 |
Employees | 10,933 |
EBITDA | -351K 415M |
Dividend yield Sector Avg | 0.21% 2.48% |
|---|---|
Next Earnings | 5 Nov 2026 |
Market Cap | 9.3B 201B |
|---|---|
Previous open | 427.99 |
Previous close | 427.8 |
Novonesis (Novozymes) B Chart
Past performance is not a reliable indicator of future results.
Related News
Novonesis (Novozymes) B Forecast
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Novonesis (Novozymes) B
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.